BTHE has the ability to have weight loss in both the prescription and OTC markets. SugarDown needs a phase IV, post market introduction study. Such a study could be conducted for $200-$250,000 . This would lift the product from the hyped products that don’t live up to their claims. With such a study, health care professionals will recommend the product. It is effective with minimal side effects.,